Andorra vs Dominican Republic: Average non-HDL cholesterol levels
Andorra
3.6
in 2018
Dominican Republic
3.6
in 2018
Andorra rank
30th
Dominican Republic rank
30th
Average non-HDL cholesterol levels over time
- Andorra
- Dominican Republic
How they compare
Andorra currently reports 3.6 against 3.6 in Dominican Republic, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Andorra ahead.
Andorra ranks 30th and Dominican Republic ranks 30th of 191 countries.
Andorra has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Andorra | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4.67 | 3.4 | 1.27 | Andorra |
| 1990s | 4.32 | 3.4 | 0.92 | Andorra |
| 2000s | 3.95 | 3.45 | 0.5 | Andorra |
| 2010s | 3.67 | 3.57 | 0.1 | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Andorra or Dominican Republic?
- Andorra, at 3.6 against 3.6 in Dominican Republic as of 2018.
- What is the difference in average non-hdl cholesterol levels between Andorra and Dominican Republic?
- 0, with Andorra ahead.
- How many years of comparable data are there for Andorra and Dominican Republic?
- 39 years are reported by both, from 1980 to 2018.
- How do Andorra and Dominican Republic rank globally for average non-hdl cholesterol levels?
- Andorra ranks 30th and Dominican Republic ranks 30th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.